Literature DB >> 12429821

Analysis of gelatinases in complex biological fluids and tissue extracts.

Francis J Descamps1, Erik Martens, Ghislain Opdenakker.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12429821     DOI： 10.1097/01.lab.0000038556.54069.73

Source DB:  PubMed          Journal:  Lab Invest        ISSN： 0023-6837            Impact factor:   5.662


× No keyword cloud information.
  14 in total

1.  Fusion Peptides CPU1 and CPU2 Inhibit Matrix Metalloproteinases and Protect Mice from Endotoxin Shock Within a Strict Time Window.

Authors:  Zheng Qiu; Fengguo Zhang; Chengxin Gong; Hanmei Xu; Jialiang Hu
Journal:  Inflammation       Date:  2015-12       Impact factor: 4.092

2.  Regulation of invasive behavior by vascular endothelial growth factor is HEF1-dependent.

Authors:  J T Lucas; B P Salimath; M G Slomiany; S A Rosenzweig
Journal:  Oncogene       Date:  2010-05-24       Impact factor: 9.867

3.  VEGF-A recruits a proangiogenic MMP-9-delivering neutrophil subset that induces angiogenesis in transplanted hypoxic tissue.

Authors:  Gustaf Christoffersson; Evelina Vågesjö; Jennifer Vandooren; Majken Lidén; Sara Massena; Rachel B Reinert; Marcela Brissova; Alvin C Powers; Ghislain Opdenakker; Mia Phillipson
Journal:  Blood       Date:  2012-09-10       Impact factor: 22.113

4.  Activation of human neutrophils by Esenbeckia leiocarpa: comparison between the crude hydroalcoholic extract (CHE) and an alkaloid (Alk) fraction.

Authors:  Rafael de Liz; Heros Horst; Moacir Geraldo Pizzolatti; Tânia Silvia Fröde; Denis Girard
Journal:  J Inflamm (Lond)       Date:  2012-05-28       Impact factor: 4.981

5.  Inhibitory Monoclonal Antibodies against Mouse Proteases Raised in Gene-Deficient Mice Block Proteolytic Functions in vivo.

Authors:  Ida K Lund; Morten G Rasch; Signe Ingvarsen; Jesper Pass; Daniel H Madsen; Lars H Engelholm; Niels Behrendt; Gunilla Høyer-Hansen
Journal:  Front Pharmacol       Date:  2012-06-28       Impact factor: 5.810

6.  Heterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants.

Authors:  Rocco Rossano; Marilena Larocca; Lea Riviello; Maria Gabriella Coniglio; Jennifer Vandooren; Grazia Maria Liuzzi; Ghislain Opdenakker; Paolo Riccio
Journal:  J Cell Mol Med       Date:  2014-02       Impact factor: 5.310

7.  Thymocyte development in the absence of matrix metalloproteinase-9/gelatinase B.

Authors:  Natalia V Gounko; Erik Martens; Ghislain Opdenakker; Vasily Rybakin
Journal:  Sci Rep       Date:  2016-07-19       Impact factor: 4.379

8.  Inhibition of Matrix Metalloproteinase 9 Enhances Rod Survival in the S334ter-line3 Retinitis Pigmentosa Model.

Authors:  Jung-A Shin; Hwa Sun Kim; Andrew Vargas; Wan-Qing Yu; Yun Sung Eom; Cheryl Mae Craft; Eun-Jin Lee
Journal:  PLoS One       Date:  2016-11-28       Impact factor: 3.240

9.  Intradermal air pouch leukocytosis as an in vivo test for nanoparticles.

Authors:  Jennifer Vandooren; Nele Berghmans; Chris Dillen; Ilse Van Aelst; Isabelle Ronsse; Liron Limor Israel; Ina Rosenberger; Jörg Kreuter; Jean-Paul Lellouche; Shulamit Michaeli; Erica Locatelli; Mauro Comes Franchini; Miren K Aiertza; Laura Sánchez-Abella; Iraida Loinaz; Dylan R Edwards; Louis Shenkman; Ghislain Opdenakker
Journal:  Int J Nanomedicine       Date:  2013-12-13

10.  Inhibition of gelatinase B/MMP-9 does not attenuate colitis in murine models of inflammatory bowel disease.

Authors:  Magali de Bruyn; Christine Breynaert; Ingrid Arijs; Gert De Hertogh; Karel Geboes; Greet Thijs; Gianluca Matteoli; Jialiang Hu; Jo Van Damme; Bernd Arnold; Marc Ferrante; Séverine Vermeire; Gert Van Assche; Ghislain Opdenakker
Journal:  Nat Commun       Date:  2017-05-31       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.